National Bank Of Canada Immunity Bio, Inc. Transaction History
National Bank Of Canada
- $72.7 Billion
- Q3 2024
A detailed history of National Bank Of Canada transactions in Immunity Bio, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 84,400 shares of IBRX stock, worth $263,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,400
Previous 84,400
-0.0%
Holding current value
$263,328
Previous $313,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IBRX
# of Institutions
205Shares Held
70MCall Options Held
1.64MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$52.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$35.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$12 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$7.01 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.25B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...